Two grass pollen tablets commercially available for allergy immunotherapy display different IgE epitope repertoires

ConclusionsCompared to the 1-grass tablet, the 5-grass tablet generally covers better the sensitization profiles of European patients, especially patients from Southern Europe, in principle less exposed to pollen from Timothy than from other grasses. The 5-grass tablet is therefore expected to elicit larger spectra of blocking antibodies, which might have implications in light of the generally accepted mechanisms of allergy immunotherapy.

http://link.springer.com/10.1186/s13601-019-0253-z

Source: Clinical and Translational Allergy - February 27, 2019 Category: Allergy & Immunology Source Type: research